Pharma Whitepapers

Biomedtracker

Biopharma Partnering and Financing Trends, H1 2020 Whitepaper

Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry

Biomedtracker

2021 Clinical Development Success Rates

This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

Pharma Brand Awareness

Developing high quality content for the pharma industry

To reach today’s Pharma decision makers, you must provide the right high-quality content to help them make educated purchasing decisions – and become loyal customers.

Citeline

Depression New Insights Shifting the Treatment Paradigm Whitepaper

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.

Datamonitor Healthcare

Datamonitor Healthcare's Top Research Reports

Datamonitor Healthcare, Biomedtracker

COVID-19 and the impact on the clinical trial space

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Citeline

Breast Cancer Clinical Landscape and Recent Trends Whitepaper

Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.

Biomedtracker

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

Citeline

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis

The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.